On top of the recent report identifying HuR as a potential regulator of bone hemostasis in osteoporosis models [30], our findings further underscore the potential for studying how HuR‐mediated processes could be targeted to reduce the impact of loss of bone density associated with aging and frailty. This evidence concerns the gene ELAVL1 and osteoporosis.